Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1.
about
Autoimmune liver serology: current diagnostic and clinical challengesVisualization of Egypt 101 virus in the mouse's brain and in cultured human carcinoma cells by means of fluorescent antibodyThe soluble puzzle of cancer control.14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasionEpstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.Microinjected Xenopus oocytes synthesize active human plasminogen activator.Histochemical observations on the role of stromal aminopeptidase activity following neoplastic cell (H.Ep. No.3) invasion.Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphataseSpecificity of antibodies to the purified Con A acceptor glycoproteins of cultured tumour cells.Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes.Histamine formation and tumor growth.Transplantation from man to mouse of exudates containing tumour cells.Human tumours in cortisone-treated mice.The epidemiology of respiratory infection in an isolated Antarctic community.Studies on the increase of vaccine virus in cultured human cells by means of the fluorescent antibody techniqueInduction of plasminogen activator synthesis by antibodies.Purification and immunological characterization of types 4 and 5 adenovirus-soluble antigensAN UNIDENTIFIED, FILTRABLE AGENT ISOLATED FROM TRANSPLANTED HUMAN TUMORSTumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic disseminationThe effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.Preparation and in vivo study of 124I-labelled monoclonal antibody H17E2 in a human tumour xenograft model. A prelude to positron emission tomography (PET).Succinic dehydrogenase and cytochrome oxidase activities in cell cultures.Observations of measles virus infection of cultured human cells. I. A study of development and spread of virus antigen by means of immunofluorescencePrediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay.Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancyTumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.Tissue-specific and species-specific esterases.Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.
P2860
Q24644140-51CBFD0C-A268-46D3-B516-B15BB853CD7CQ27483752-7BDFF7FE-18D3-43BF-9036-C398569222AAQ33338859-6AAD6F40-E318-4A0B-9F4B-F30DA67F8FAAQ33611289-6A41494D-BD56-4EA1-9D1A-2E45A61F7E81Q33760239-B76C9D35-EE01-4B78-A0A3-691C780B832AQ35581806-9DC1E713-0D4D-4A8A-B271-1A64735436D4Q35739978-6A295F18-C21B-4FC9-889E-F0CA9538C449Q35930107-27D7A967-27B7-4266-BC47-EC9DDBB3BA03Q35977370-E7AEF4FF-3286-499F-B0B1-0FF278CC0934Q36027385-9D4BCA23-2A94-42A9-9A55-5A8E93798A5CQ36027441-4A4C89F4-2C2A-4368-BC4E-8CDE6323E9E2Q36126953-58615A9B-15E5-472E-92B0-7B2F9D26BE62Q36132658-66CA4033-6724-44D0-8847-223C9D7AC8C3Q36132879-01D8E384-B616-49B6-A3DD-EEDC40C6ECFCQ36252316-5CF83E53-CA75-4670-918E-C48C990610AEQ36262811-973780EA-3FDA-4F71-B6A6-772C3C6F4191Q36345431-ABAE61BA-C156-406A-A8AC-2EBF9C05A363Q36407268-53F2129F-387D-4212-8EB9-20D13A4BED64Q36438296-FF445D7F-B540-40E0-95CF-F28423E0C993Q37125854-738F2C7B-1800-4B3E-AC33-32E9369F6EEFQ37635689-ED005D08-D726-42D7-B663-A63939325AC5Q37735525-1F9C42FB-BE2B-4E5A-A224-687F9268CC56Q41580011-9E3FB970-9166-4741-85EC-47AB6E39A3D5Q41728479-CE2CE90B-664A-41B1-B97E-62A6FB977DB8Q41915431-4769CC51-AD8A-4FA2-9110-08A84D7055D3Q41915562-8F2DD16E-3C30-4316-9902-81A12FCA9E21Q42014522-073D0A68-EC4A-4F67-A447-86999314ADDBQ42154053-3FA5CCD4-BE94-4A1B-A82A-552463CE2B11Q42256420-D02DBFA4-30BB-4B16-89CA-15116B126CC5Q42478267-97754245-A440-433F-B05B-94714E58BF2CQ42963599-AB1EF1CD-82BB-4326-8CAE-6CA79E4451C5Q55148658-AC03496F-5906-4C1E-8661-CCCFF82CD4FA
P2860
Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1954
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@en
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@nl
type
label
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@en
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@nl
prefLabel
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@en
Transplantable human neoplasms ...... p. No. 3; and H.Emb.Rh. No. 1.
@nl
P4510
P1433
P1476
Transplantable human neoplasms ...... Ep. No. 3; and H.Emb.Rh. No. 1
@en
P2093
H W TOOLAN
P304
P407
P577
1954-10-01T00:00:00Z